Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock

World News: . []

HOUSTON April 16 2018 GLOBE NEWSWIRE -- Bellicum Pharmaceuticals Inc NASDAQBLCM a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders t oday an...

More news and information about Bellicum Pharmaceuticals, Inc.

Published By:

Globe Newswire: 21:42 GMT Monday 16th April 2018

Published: .

Search for other references to "bellicum" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us